Short Interest in Lexaria Bioscience Corp. (NASDAQ:LEXXW) Decreases By 41.2%

Lexaria Bioscience Corp. (NASDAQ:LEXXW) was the target of a significant decrease in short interest during the month of February. As of February 28th, there was short interest totalling 2,000 shares, a decrease of 41.2% from the February 13th total of 3,400 shares. Based on an average daily volume of 9,100 shares, the days-to-cover ratio is currently 0.2 days.

Lexaria Bioscience Stock Performance

Shares of NASDAQ:LEXXW opened at $0.26 on Monday. Lexaria Bioscience has a 12-month low of $0.16 and a 12-month high of $2.07. The business has a 50 day moving average of $0.39 and a 200-day moving average of $0.69.

Lexaria Bioscience Company Profile

Lexaria Bioscience Corp. operates as a biotechnology company. It develops and out-licenses its patented drug delivery technology, DehydraTECH, which combines lipophilic molecules or active pharmaceutical ingredients with specific long-chain fatty acids and carrier compounds that improve the way they enter the bloodstream, increasing their effectiveness and allowing for lower overall dosing while promoting healthier oral ingestion methods.